ONEBIO LABS / RESEARCH INFORMATION
Tirzepatide
Research Peptide | Dual GIP/GLP-1 Receptor Agonist
Technical specifications
| Classification | 39-amino-acid synthetic peptide conjugate |
|---|---|
| Targets | GIP and GLP-1 receptors |
| Molecular formula | C225H348N48O68 |
| Molecular weight | 4813 g/mol |
| CAS | 2023788-19-2 |
| PubChem CID | 156588324 |
| Form | Lyophilised research peptide |
| Purity / testing | Refer to product-specific batch COA / analytical documentation |
| Intended use | Laboratory and research purposes only |
A ONE BIOLABS research-product listing should not be presented as a substitute for an approved medicinal product and should avoid dosage or treatment guidance.
01 / PRODUCT INFORMATION
Product description
Tirzepatide is a synthetic peptide agonist of the GIP and GLP-1 receptors. It is an approved prescription active ingredient in some jurisdictions and is also used as a research reference compound in metabolic and receptor-signalling studies.
02 / RESEARCH CONTEXT
Research overview
Research areas: GIP receptor signalling; GLP-1 receptor signalling; glucose and metabolic pathways; receptor pharmacology.
03 / PRODUCT INFORMATION
ONE BIOLABS quality
ONE BIOLABS provides research products with product information and available batch documentation where applicable. Batch-specific identity, purity, concentration, salt form, testing and manufacturing claims should be stated only where supported by the applicable Certificate of Analysis or other analytical documentation.
04 / STORAGE
Refrigerate at 2–8°C
Unless the product-specific label or Certificate of Analysis states otherwise, store refrigerated at 2–8°C, protected from direct light, excessive heat and moisture. Keep the container securely closed. Product-specific storage instructions and stability data should take precedence.
Important notice
FOR RESEARCH PURPOSES ONLY. This product information is intended for laboratory and research reference. Products described in this document are not intended for human consumption, self-administration, diagnosis, treatment, prevention or cure of disease unless supplied as an appropriately authorised medicinal product through lawful channels. No dosage, administration or therapeutic guidance is provided.
Research findings, especially preclinical findings, should not be interpreted as proof of human safety or efficacy.
Reviews
There are no reviews yet.